蛋白酸酶2A 通过增加CD28刺激成本,促进CD8+T细胞效应器功能
Kaixiang Zhu1,2,3, Deepak Rohila4,5, Yuanling Zhao4
1Department of Cardiology of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Research (Washington, D.C.)
|January 6, 2025
概括
蛋白酸酶2A (PP2A) 对于CD8+T细胞效应器功能至关重要. 消去PP2A Cα通过破坏CD28共刺激,损害T细胞增殖,细胞因子生产和抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 蛋白酸酶2A (PP2A) 是细胞过程的关键调节者.
- 之前的研究强调了PP2A在CD4+T细胞和胸细胞发育中的作用.
- 在CD8+T细胞中PP2A的功能在很大程度上是未知的.
研究的目的:
- 研究PP2A催化子单元α (Cα) 在CD8+T细胞效应器功能中的作用.
- 阐明PP2A Cα缺乏对体外和体内免疫反应的影响.
- 了解PP2A对T细胞激活的影响的分子机制.
主要方法:
- 在CD8+ T细胞中,PP2A Cα亚单元的基因切除.
- 在体外刺激测试以评估细胞增殖和细胞因子的产生.
- 使用病毒感染和瘤模型的体内研究.
- 信号通路的分析,包括AKT酸化.
主要成果:
- 在CD8+ T细胞中,PP2A Cα缺乏导致细胞增殖和细胞因子产生减少.
- 在T细胞中缺乏PP2A Cα的小鼠表现出抗病毒免疫力受损和抗瘤活性减弱.
- 观察到PP2A Cα缺乏的CD8+ T细胞减少透到瘤中.
- PP2A Cα 缺乏障碍了 CD28 诱导的 AKT 酸化,阻碍了 T 细胞的共刺激.
结论:
- PP2A对于促进CD8+T细胞效应器功能至关重要.
- PP2A Cα 缺乏会影响适应性免疫和抗瘤反应.
- PP2A 作为 CD28 介导 CD8+ T 细胞中 CD28 介导的辅助刺激信号的关键调节者.
相关概念视频
00:50Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
01:22Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
01:22T Cell Activation and Clonal Selection
522
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
522
02:54Protein Kinases and Phosphatases
12.8K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
02:34Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K